BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19005008)

  • 21. Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
    Imanishi Y; Hashimoto J; Ando W; Kobayashi K; Ueda T; Nagata Y; Miyauchi A; Koyano HM; Kaji H; Saito T; Oba K; Komatsu Y; Morioka T; Mori K; Miki T; Inaba M
    J Bone Miner Metab; 2012 Jan; 30(1):93-9. PubMed ID: 21739089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Welcome to MEPE in the renal proximal tubule.
    Friedlander G
    Nephrol Dial Transplant; 2010 Oct; 25(10):3135-6. PubMed ID: 20798122
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets.
    Bresler D; Bruder J; Mohnike K; Fraser WD; Rowe PS
    J Endocrinol; 2004 Dec; 183(3):R1-9. PubMed ID: 15590969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.
    Pereira RC; Juppner H; Azucena-Serrano CE; Yadin O; Salusky IB; Wesseling-Perry K
    Bone; 2009 Dec; 45(6):1161-8. PubMed ID: 19679205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif.
    Zelenchuk LV; Hedge AM; Rowe PS
    Bone; 2015 Oct; 79():131-42. PubMed ID: 26051469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Phosphatonins" and the regulation of phosphorus homeostasis.
    Berndt TJ; Schiavi S; Kumar R
    Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1170-82. PubMed ID: 16275744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphate sensing.
    Kumar R
    Curr Opin Nephrol Hypertens; 2009 Jul; 18(4):281-4. PubMed ID: 19352177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phosphatonins and the regulation of phosphate homeostasis.
    Kumar R
    Ann Endocrinol (Paris); 2006 Apr; 67(2):142-6. PubMed ID: 16639365
    [No Abstract]   [Full Text] [Related]  

  • 29. PHEX, FGF23, DMP1 and beyond.
    Strom TM; Jüppner H
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):357-62. PubMed ID: 18660670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
    Zhang GX; Mizuno M; Tsuji K; Tamura M
    Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [FGF23, a "new" hormone regulating phosphate homeostasis and vitamin D metabolism].
    Silve C
    Presse Med; 2005 Nov; 34(19 Pt 1):1384-90. PubMed ID: 16292192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium stimulates renal phosphate reabsorption.
    Thumfart J; Jung S; Amasheh S; Krämer S; Peters H; Sommer K; Biber J; Murer H; Meij I; Querfeld U; Wagner CA; Müller D
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1126-33. PubMed ID: 18701629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1.
    Liu S; Wang H; Wang X; Lu L; Gao N; Rowe PS; Hu B; Wang Y
    Nucleic Acids Res; 2009 Dec; 37(22):7447-54. PubMed ID: 19808933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporter.
    Bacic D; Wagner CA; Hernando N; Kaissling B; Biber J; Murer H
    Kidney Int Suppl; 2004 Oct; (91):S5-S12. PubMed ID: 15461703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active sites of human MEPE-ASARM regulating bone matrix mineralization.
    Minamizaki T; Sakurai K; Hayashi I; Toshishige M; Yoshioka H; Kozai K; Yoshiko Y
    Mol Cell Endocrinol; 2020 Nov; 517():110931. PubMed ID: 32712387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density.
    Jain A; Fedarko NS; Collins MT; Gelman R; Ankrom MA; Tayback M; Fisher LW
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4158-61. PubMed ID: 15292364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D reduces renal NaPi-2 in PTH-infused rats: complexity of vitamin D action on renal P(i) handling.
    Friedlaender MM; Wald H; Dranitzki-Elhalel M; Zajicek HK; Levi M; Popovtzer MM
    Am J Physiol Renal Physiol; 2001 Sep; 281(3):F428-33. PubMed ID: 11502592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
    Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
    Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.
    Rowe PS; de Zoysa PA; Dong R; Wang HR; White KE; Econs MJ; Oudet CL
    Genomics; 2000 Jul; 67(1):54-68. PubMed ID: 10945470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypophosphatemia: an update on its etiology and treatment.
    Gaasbeek A; Meinders AE
    Am J Med; 2005 Oct; 118(10):1094-101. PubMed ID: 16194637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.